Cargando…

State-of-the-art combination treatment strategies for advanced stage non–small cell lung cancer

Non–small cell lung cancer (NSCLC) is the most abundant type of epithelial lung cancer being diagnosed after 40% of invasions of excrescence in pulmonary tissues. According to WHO, 30% of NSCLC patients can be cured if diagnosed and treated early. Mutations play an important role in advanced stage N...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yao, Yongfang, Fareed, Rameesha, Zafar, Aliya, Saleem, Kalsoom, Huang, Tao, Duan, Yongtao, Rehman, Masood Ur
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376330/ https://www.ncbi.nlm.nih.gov/pubmed/35978836 http://dx.doi.org/10.3389/fonc.2022.958505

Ejemplares similares

Evaluation of clinical trials of ethnomedicine used for the treatment of diabetes: A systematic review
por: Elmi, Gul Rehman, et al.
Publicado: (2023)

Herbal therapies in gastrointestinal and hepatic disorders: An evidence-based clinical review
por: Yao, Yongfang, et al.
Publicado: (2022)

Advances in Sensor Technologies in the Era of Smart Factory and Industry 4.0 †
por: Kalsoom, Tahera, et al.
Publicado: (2020)

Recent advances in immune checkpoint inhibitors for non-small lung cancer treatment
por: Altaf, Reem, et al.
Publicado: (2022)

Advances in body-centric wireless communication: applications and state-of-the-art
por: Abbasi, Qammer H, et al.
Publicado: (2016)

Development and in vitro Evaluation of Gastro-protective Aceclofenac-loaded Self-emulsifying Drug Delivery System
por: Jianxian, Chen, et al.
Publicado: (2020)

Advanced diagnostic and therapeutic strategies in nanotechnology for lung cancer
por: Duan, Yujuan, et al.
Publicado: (2022)

The immunotherapy advancement targeting malignant blastomas in early childhood
por: Zang, Bolun, et al.
Publicado: (2023)

Practice Patterns of Treatment Strategy of Limited-Stage Small-Cell Lung Cancer: Survey of Chinese Oncologists
por: Xu, Chang, et al.
Publicado: (2022)

Immunotherapy progress and clinical strategy of unresectable locally advanced non-small cell lung cancer
por: Zhang, Xiaofei, et al.
Publicado: (2023)

Inclusion of “Toxicological Review Expiry Dates” in Art Material Labels May Further Reduce the Risk of Chronic Toxicity, Including That of Cancer
por: Shammas, Masood A., et al.
Publicado: (2016)

Current and novel therapeutic strategies for optimizing immunotherapy outcomes in advanced non-small cell lung cancer
por: Martin, Claudio, et al.
Publicado: (2022)

State-of-the-art therapeutic strategies for targeting cancer stem cells in prostate cancer
por: Ramesh, Saravanan, et al.
Publicado: (2023)

Strategies of Dose Escalation in the Treatment of Locally Advanced Non-Small Cell Lung Cancer: Image Guidance and Beyond
por: Chi, Alexander, et al.
Publicado: (2014)

State-of-the-Art Research on “Lymphomas: Role of Molecular Imaging for Staging, Prognostic Evaluation, and Treatment Response”
por: Kostakoglu, Lale, et al.
Publicado: (2013)

Discussion on the Treatment Strategy for Stage ⅡA1 Cervical Cancer (FIGO 2018)
por: Chen, Xiaolin, et al.
Publicado: (2022)

Towards Supply Chain Visibility Using Internet of Things: A Dyadic Analysis Review
por: Ahmed, Shehzad, et al.
Publicado: (2021)

Editorial: State of the art body composition profiling: Advances in imaging modalities and patient outcomes
por: Petrella, Francesco, et al.
Publicado: (2022)

Triapine Radiochemotherapy in Advanced Stage Cervical Cancer
por: Kunos, Charles A., et al.
Publicado: (2018)

Induction Strategy for Locally Advanced Thymoma
por: Zhang, Yang, et al.
Publicado: (2021)

Clinical Evaluation of Serum Tumor Markers in Patients With Advanced-Stage Non-Small Cell Lung Cancer Treated With Palliative Chemotherapy in China
por: Abbas, Muhammad, et al.
Publicado: (2020)

nab-Paclitaxel Plus Durvalumab in Patients With Previously Treated Advanced Stage Non-small Cell Lung Cancer (ABOUND.2L+)
por: Morgensztern, Daniel, et al.
Publicado: (2021)

Survival Following Segmentectomy or Lobectomy in Patients With Stage IB Non-small-cell Lung Cancer
por: Hao, Bo, et al.
Publicado: (2020)

TP53 Co-Mutations in Advanced EGFR-Mutated Non–Small Cell Lung Cancer: Prognosis and Therapeutic Strategy for Cancer Therapy
por: Liu, Surui, et al.
Publicado: (2022)

Serum Levels of OX40 in Early and Late-Stage Oral Squamous Cell Carcinoma
por: Sani, Aliya I, et al.
Publicado: (2021)

Cryoablation for advanced non-small cell lung cancer: a protocol for a systematic review
por: Duan, Hua, et al.
Publicado: (2020)

Radiation Therapy in Extensive Stage Small Cell Lung Cancer
por: Jeremic, Branislav, et al.
Publicado: (2017)

Outcome of immune checkpoint inhibitors in patients with extensive-stage small-cell lung cancer and brain metastases
por: Wang, Chunyu, et al.
Publicado: (2023)

NISQE: Non-Intrusive Speech Quality Evaluator Based on Natural Statistics of Mean Subtracted Contrast Normalized Coefficients of Spectrogram
por: Zafar, Shakeel, et al.
Publicado: (2023)

Small and Innovative Molecules as New Strategy to Revert MDR
por: Zinzi, Laura, et al.
Publicado: (2014)

An open, observational clinical study of neoadjuvant therapy in resectable stage III non-small cell lung cancer
por: Qi, Yuwen, et al.
Publicado: (2023)

Locally Advanced Breast Cancer – Strategies for Developing Nations
por: Balogun, Onyinye D., et al.
Publicado: (2015)

Editorial: Advances in the Pathogenesis and Therapeutic Strategies for Nasopharyngeal Carcinoma
por: Yang, Kai-Bin, et al.
Publicado: (2021)

Immunotherapeutic Strategies in Chronic Lymphocytic Leukemia: Advances and Challenges
por: Perutelli, Francesca, et al.
Publicado: (2022)

Adjuvant Chemotherapy for Early Stage Non-Small Cell Lung Cancer
por: Patel, Manali I., et al.
Publicado: (2011)

Surgical Management of Stage IIIA Non-Small Cell Lung Cancer
por: Van Schil, Paul E., et al.
Publicado: (2017)

Neoadjuvant Chemoradiotherapy for Stage III Non-Small Cell Lung Cancer
por: Sher, David J.
Publicado: (2017)

Metastatic prostate tumor to testes: Sign of advance disease
por: Ahmed, Syed Adeel, et al.
Publicado: (2023)

Checkpoint inhibitors as dual immunotherapy in advanced non-small cell lung cancer: a meta-analysis
por: Alifu, Muyesar, et al.
Publicado: (2023)

Advances of Tumorigenesis, Diagnosis at Early Stage, and Cellular Immunotherapy in Gastrointestinal Malignancies
por: Zhu, Haipeng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_djfvkcq3pbc269k18s9piiduo2